SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline

by NASDAQ Market News December 2, 2021

NASDAQ Market News
Click here to email author

Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan

Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

Ads